Search - tctmd.com

Displaying 941 - 960 of 3616

Sort: Relevancy | Date

News Industry News

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

October 12, 2015

News Conference News TCT 2015

DRAGON: Transradial as Effective as Transfemoral in Ad Hoc PCI, With Less Risk of Bleeding

October 12, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

Despite Setbacks, Research Into Myocardial Salvage Continues

October 12, 2015

News Conference News TCT 2015

DAPT Study Subanalysis Focuses on EES Subgroup

October 12, 2015

News Conference News TCT 2015

CT-Derived FFR Could Improve Efficiency of Referral to ICA

October 12, 2015

News Conference News TCT 2015

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

October 12, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Industry News

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

News Conference News TCT 2015

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

News Conference News TCT 2015

Very Late Stent Thrombosis Remains an Important Clinical Target

October 12, 2015

News Industry News

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

Presentation TCT 2015

The 10 Most Common Statistical Mistakes and Misinterpretations I See Again and Again

Presenter: Robert A. Harrington, Pascal Vranckx, Sanjay Kaul

October 11, 2015

Presentation TCT 2015

When Is the Primary Endpoint Not Enough? Pitfalls in Primary Endpoint Selection and Assumptions, Power, and More

Presenter: Robert A. Harrington, Pascal Vranckx

October 11, 2015

Presentation TCT 2015

How to Assess the Quality of Evidence From Peer-Reviewed Manuscripts: The Statistical Reviewers Vantage Point

Presenter: Robert A. Harrington, Pascal Vranckx, Jan Tijssen

October 11, 2015

Advertisement

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

DRAGON: Transradial as Effective as Transfemoral in Ad Hoc PCI, With Less Risk of Bleeding

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

Despite Setbacks, Research Into Myocardial Salvage Continues

DAPT Study Subanalysis Focuses on EES Subgroup

CT-Derived FFR Could Improve Efficiency of Referral to ICA

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

Absorb BVS Matches Xience V in Chinese Patients

Very Late Stent Thrombosis Remains an Important Clinical Target

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

The 10 Most Common Statistical Mistakes and Misinterpretations I See Again and Again

When Is the Primary Endpoint Not Enough? Pitfalls in Primary Endpoint Selection and Assumptions, Power, and More

How to Assess the Quality of Evidence From Peer-Reviewed Manuscripts: The Statistical Reviewers Vantage Point

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content